20-168
Showing 1 - 25 of >10,000
Ulcerative Colitis or Crohn's Disease Receiving Vedolizumab in
Recruiting
- Inflammatory Bowel Disease (IBD)
- +2 more
-
Wroclaw, Dolnoslskie, Poland
- +10 more
Sep 12, 2022
Lanadelumab in Persons With Hereditary Angioedema in Poland
Recruiting
- Hereditary Angioedema (HAE)
-
Wrocław, Dolnośląskie, Poland
- +13 more
Jun 15, 2022
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Acalabrutinib
- +2 more
-
Tucson, Arizona
- +40 more
Dec 20, 2022
Lupus Erythematosus, Systemic Trial in Worldwide (BIIB059, BIIB059 matching )
Recruiting
- Lupus Erythematosus, Systemic
- BIIB059
- BIIB059 matching placebo
-
Upland, California
- +41 more
Apr 19, 2022
Bladder Cancer, Biliary Tract Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Rare Tumors Trial
Active, not recruiting
- Bladder Cancer, Biliary Tract Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Rare Tumors
- Trastuzumab deruxtecan
-
Duarte, California
- +75 more
Jul 15, 2022
Healthy Infants Trial in Bulgaria, Hungary, Poland (Starter Infant Formula, Follow-up Formula, and Growing-up Milk Supplemented
Completed
- Healthy Infants
- Starter Infant Formula, Follow-up Formula, and Growing-up Milk Supplemented With a Blend of Five Human Milk Oligosaccharides
- +2 more
-
Blagoevgrad, Bulgaria
- +33 more
Feb 16, 2022
Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)
Active, not recruiting
- Spondylitis, Ankylosing
- CC-99677
- Placebo
-
Flagstaff, Arizona
- +139 more
Dec 9, 2022
Frailty Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Frailty
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 2, 2023
Osteo Arthritis Knee Trial in Abu Dhabi (Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Osteo Arthritis Knee
- Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Abu Dhabi, United Arab EmiratesBurjeel Medical City
Oct 11, 2023
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +4 more
-
West Hollywood, California
- +101 more
Jan 16, 2023
Post-Extubation Assessment of Clinical Stability in ELBW Infants
Not yet recruiting
- Extremely Low Birth Weight Infants
- Oxygen saturation probe
- +2 more
-
Montreal, Quebec, Canada
- +1 more
Sep 7, 2023
Ulcerative Colitis, Crohn's Disease Trial in Worldwide (UTTR1147A)
Completed
- Ulcerative Colitis
- Crohn's Disease
-
Greenville, North Carolina
- +56 more
Jul 26, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib 20 mg/m^2
- +4 more
-
Gilbert, Arizona
- +107 more
Dec 20, 2022
Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)
Recruiting
- Sjogren's Syndrome
- Placebo
- +2 more
-
Anniston, Alabama
- +77 more
Aug 18, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
-
New Port Richey, Florida
- +94 more
Nov 30, 2022
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS
Completed
- Atopic Dermatitis
- Cosmetic study
-
Rio de Janeiro, BrazilCIDP
Mar 13, 2023
Osteoarthritis, Knee Pain Trial in Washington, Tyler (SL-1002, Placebo)
Recruiting
- Osteoarthritis, Knee Pain
- SL-1002
- Placebo
-
Washington, District of Columbia
- +1 more
Jul 20, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))
Active, not recruiting
- Multiple Myeloma
- Elranatamab (PF-06863135)
-
Beverly Hills, California
- +75 more
Oct 4, 2022
ABPA Trial in Scottsdale, Santa Monica, Tampa (Itraconazole Powder, Placebo)
Recruiting
- ABPA
- Itraconazole Powder
- Placebo
-
Scottsdale, Arizona
- +2 more
Feb 1, 2023
